For example, high EZH2 expression has been associated with poor prognosis in a series of colorectal cancer patients by Wang et al. [33], whereas high EZH2 expression was found to be associated with better relapse-free survival in colon cancer patients (but not in rectal cancer patients) by Fluge et al. [34]. Here, EZH2 is linked to colorectal cancer.